Defining the time of fetal or perinatal acquisition of human immunodeficiency virus type 1 infection on the basis of age at first positive culture

Journal of Infectious Diseases

Volumn 175, Issue 3, 1997, Pages 712-715

  Kalish, Leslie A ^a   Pitt, Jane ^b   Lew, Judy ^b   Landesman, Sheldon ^b   Diaz, Clemente ^b   Hershow, Ronald ^b   Hollinger, F Blaine ^b   Pagano, Marcello ^b   Smeriglio, Vincent ^b   Moye, Jack ^b  

^a NEW ENGLAND RESEARCH INSTITUTES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

AGE; ARTICLE; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; PERINATAL INFECTION; PRIORITY JOURNAL; VERTICAL TRANSMISSION; VIRUS CULTURE; VIRUS TRANSMISSION;

EID: 16944362076     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/175.3.712     Document Type: Article

References (14)

1. Mofenson LM. A critical review of studies evaluating the relationship of mode of delivery to perinatal transmission of human immunodeficiency virus. Pediatr Infect Dis J 1995;14:169-77.
2. Kuhn L, Stein ZA. Mother-to-infant HIV transmission: timing, risk factors and prevention. Paediatr Perinatal Epidemiol 1995;9:1-29.
3. Dunn DT, Brandt CD, Krivine A, et al. The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmission. AIDS Res Hum Retroviruses 1995;9:F7-11.
4. Rouzioux C, Costagliola D, Burgard M, et al. Estimated timing of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission by use of a Markov model. Am J Epidemiol 1995; 142:1330-7.
5. Dickover RE, Garratty EM, Herman SA, et al. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effects of maternal zidovudine treatment on viral load. JAMA 1996; 275:599-605.
6. Bryson YJ, Luzuriaga K, Sullivan JL, Wara DW. Proposed definitions for in utero versus intrapartum transmission of HIV-1. N Engl J Med 1992; 327:1246-7.
7. Sheon AR, Fox HE, Rich KC, et al. The Women and Infants Transmission Study (WITS) of maternal-infant HIV transmission: study design, methods and baseline data. J Women's Health 1996;5:69-78.
8. Hollinger B, ed. ACTG virology manual for HIV laboratories. Version 2.1. Bethesda, MD: National Institutes of Health, 1993.
9. Hollinger FB, Bremer JW, Myers LE, Gold JWM, McQuay L, the NIH/ NIAID/DAIDS/ACTG Virology Laboratories. Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group. J Clin Microbiol 1992;30:1787-94.
10. Turnbull BW. The empirical distribution function with arbitrarily grouped, censored and truncated data. J R Stat Soc B 1976;38:290-5.
11. So Y. Interval censored data. In: Proceedings of the 19th annual SAS Users Group International Conference. Cary, NC: SAS Institute, 1994:1107-13.
12. McIntosh K, Pitt J, Brambilla D, et al. Blood culture in the first 6 months of life for the diagnosis of vertically transmitted human immunodeficiency virus infection. J Infect Dis 1994;170:996-1000.
13. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 1996;271:1582-6.
14. Mayaux MJ, Burgard M, Teglas JP, et al. Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease. JAMA 1996;275:606-10.